David de Graaf now has his $28.5M launch round in place, building a coenzyme A platform in his latest startup

Longtime biotech exec David de Graaf has the cash he needs to set up the preclinical foundation for his coenzyme A metabolism company Comet. A …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

David de Graaf now has his $28.5M launch round in place, build­ing a coen­zyme A plat­form in his lat­est start­up